B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis.
De Vitis C, D'Ascanio M, Sacconi A, Pizzirusso D, Salvati V, Mancini M, Scafetta G, Cirombella R, Ascenzi F, Bruschini S, Esposito A, Castelli S, Salvucci C, Teodonio L, Sposato B, Catizone A, Di Napoli A, Vecchione A, Ciliberto G, Sciacchitano S, Ricci A, Mancini R.
De Vitis C, et al.
Int J Mol Sci. 2022 Nov 30;23(23):15040. doi: 10.3390/ijms232315040.
Int J Mol Sci. 2022.
PMID: 36499368
Free PMC article.
There are no accurate biomarkers available so far. Our aim was to evaluate the expression of the B4GALT1 in patients with IPF. Analysis of B4GALT1 gene expression was performed in silico on two gene sets, retrieved from the Gene Expression Omnibus database. ...Netwo …
There are no accurate biomarkers available so far. Our aim was to evaluate the expression of the B4GALT1 in patients with IPF. Analys …